Veradigm Retained Earnings (Accumulated Deficit) 2010-2022 | MDRX
Veradigm retained earnings (accumulated deficit) from 2010 to 2022. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Veradigm Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2022 | $646 |
| 2021 | $720 |
| 2020 | $633 |
| 2019 | $-49 |
| 2018 | $133 |
| 2017 | $-338 |
| 2016 | $-187 |
| 2015 | $-190 |
| 2014 | $-188 |
| 2013 | $-122 |
| 2012 | $-18 |
| 2011 | $-16 |
| 2010 | $-90 |
| 2010 | $-84 |
| 2009 | $-147 |
| Veradigm Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2022-12-31 | $646 |
| 2022-09-30 | $753 |
| 2022-06-30 | $739 |
| 2022-03-31 | $803 |
| 2021-12-31 | $720 |
| 2021-09-30 | $680 |
| 2021-06-30 | $664 |
| 2021-03-31 | $642 |
| 2020-12-31 | $633 |
| 2020-09-30 | $-95 |
| 2020-06-30 | $-95 |
| 2020-03-31 | $-88 |
| 2019-12-31 | $-49 |
| 2019-09-30 | $-30 |
| 2019-06-30 | $-25 |
| 2019-03-31 | $125 |
| 2018-12-31 | $133 |
| 2018-09-30 | $-251 |
| 2018-06-30 | $-228 |
| 2018-03-31 | $-319 |
| 2017-12-31 | $-338 |
| 2017-09-30 | $-355 |
| 2017-06-30 | $-337 |
| 2017-03-31 | $-195 |
| 2016-12-31 | $-187 |
| 2016-09-30 | $-190 |
| 2016-06-30 | $-190 |
| 2016-03-31 | $-188 |
| 2015-12-31 | $-190 |
| 2015-09-30 | $-207 |
| 2015-06-30 | $-201 |
| 2015-03-31 | $-198 |
| 2014-12-31 | $-188 |
| 2014-09-30 | $-186 |
| 2014-06-30 | $-160 |
| 2014-03-31 | $-142 |
| 2013-12-31 | $-122 |
| 2013-09-30 | $-101 |
| 2013-06-30 | $-52 |
| 2013-03-31 | $-29 |
| 2012-12-31 | $-18 |
| 2012-09-30 | $7 |
| 2012-06-30 | $-3 |
| 2012-03-31 | $-11 |
| 2011-12-31 | $-16 |
| 2011-09-30 | $-41 |
| 2011-06-30 | $-61 |
| 2011-03-31 | $-77 |
| 2010-12-31 | $-90 |
| 2010-09-30 | $-84 |
| 2010-06-30 | |
| 2010-05-31 | $-84 |
| 2010-03-31 | |
| 2010-02-28 | $-100 |
| 2009-12-31 | $-117 |
| 2009-11-30 | $-119 |
| 2009-09-30 | |
| 2009-08-31 | $-134 |
| 2009-05-31 | $-147 |
| 2009-02-28 | $-161 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.449B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.134B | 48.53 |
| Tempus AI (TEM) | United States | $6.966B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.050B | 97.25 |
| Inspire Medical Systems (INSP) | United States | $4.470B | 86.83 |
| IRhythm Technologies (IRTC) | United States | $3.223B | 0.00 |
| Privia Health (PRVA) | United States | $2.873B | 215.27 |
| Schrodinger (SDGR) | United States | $1.881B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.839B | 0.00 |
| Enovis (ENOV) | United States | $1.825B | 11.29 |
| Omnicell (OMCL) | United States | $1.418B | 30.59 |
| Phreesia (PHR) | United States | $1.409B | 0.00 |
| Azenta (AZTA) | United States | $1.154B | 53.72 |
| 10x Genomics (TXG) | United States | $0.918B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.568B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.551B | 0.00 |
| Talkspace (TALK) | United States | $0.450B | 267.00 |
| Standard BioTools (LAB) | United States | $0.440B | 0.00 |
| TruBridge (TBRG) | United States | $0.363B | 0.00 |
| Claritev (CTEV) | United States | $0.325B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.270B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.189B | 0.00 |
| Pulmonx (LUNG) | United States | $0.182B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.100B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.082B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.076B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.066B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| CareCloud (CCLD) | United States | $0.060B | 2.58 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Syra Health (SYRA) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |